Qinghai Spring Medicinal Resources Technology Co Ltd (600381) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.008x

Based on the latest financial reports, Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a cash flow conversion efficiency ratio of -0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-8.22 Million ≈ $-1.20 Million USD) by net assets (CN¥1.03 Billion ≈ $151.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Qinghai Spring Medicinal Resources Technology Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Qinghai Spring Medicinal Resources Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Qinghai Spring Medicinal Resources Techn debt and liabilities for a breakdown of total debt and financial obligations.

Qinghai Spring Medicinal Resources Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qinghai Spring Medicinal Resources Technology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Changzhou Shenli Electrical Machine Incorporated Co SHG:603819	0.017x
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A SHE:002864	0.016x
Prisma Properties ST:PRISMA	-0.087x
Albaraka Turk Katilim Bankasi AS IS:ALBRK	-0.403x
STL Technology Co Ltd TWO:4931	0.090x
Man Industries (India) Limited NSE:MANINDS	-0.032x
Shenzhen Hifuture Electric SHE:002168	-0.359x
Doubledown Interactive Co Ltd NASDAQ:DDI	0.044x

Annual Cash Flow Conversion Efficiency for Qinghai Spring Medicinal Resources Technology Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Qinghai Spring Medicinal Resources Technology Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Qinghai Spring Medicinal Resources Techn.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥999.61 Million ≈ $146.27 Million	CN¥-26.41 Million ≈ $-3.86 Million	-0.026x	-133.81%
2024-12-31	CN¥1.04 Billion ≈ $151.64 Million	CN¥80.97 Million ≈ $11.85 Million	0.078x	+314.06%
2023-12-31	CN¥1.27 Billion ≈ $185.45 Million	CN¥23.92 Million ≈ $3.50 Million	0.019x	+190.91%
2022-12-31	CN¥1.53 Billion ≈ $224.32 Million	CN¥-31.82 Million ≈ $-4.66 Million	-0.021x	+40.89%
2021-12-31	CN¥1.82 Billion ≈ $266.39 Million	CN¥-63.93 Million ≈ $-9.36 Million	-0.035x	+6.78%
2020-12-31	CN¥2.07 Billion ≈ $302.77 Million	CN¥-77.95 Million ≈ $-11.41 Million	-0.038x	+61.92%
2019-12-31	CN¥2.39 Billion ≈ $349.53 Million	CN¥-236.30 Million ≈ $-34.58 Million	-0.099x	-28.13%
2018-12-31	CN¥2.38 Billion ≈ $348.68 Million	CN¥-183.97 Million ≈ $-26.92 Million	-0.077x	-287.09%
2017-12-31	CN¥2.32 Billion ≈ $339.48 Million	CN¥95.74 Million ≈ $14.01 Million	0.041x	-76.03%
2016-12-31	CN¥2.00 Billion ≈ $293.22 Million	CN¥344.99 Million ≈ $50.48 Million	0.172x	-63.62%
2015-12-31	CN¥1.76 Billion ≈ $257.31 Million	CN¥832.17 Million ≈ $121.77 Million	0.473x	+262.85%
2014-12-31	CN¥308.44 Million ≈ $45.13 Million	CN¥-89.64 Million ≈ $-13.12 Million	-0.291x	+48.24%
2013-12-31	CN¥50.03 Million ≈ $7.32 Million	CN¥-28.09 Million ≈ $-4.11 Million	-0.561x	-72.31%
2012-12-31	CN¥2.15 Billion ≈ $314.92 Million	CN¥-701.18 Million ≈ $-102.61 Million	-0.326x	-402.13%
2011-12-31	CN¥2.32 Billion ≈ $339.20 Million	CN¥249.98 Million ≈ $36.58 Million	0.108x	+117.52%
2010-12-31	CN¥-116.10 Million ≈ $-16.99 Million	CN¥71.47 Million ≈ $10.46 Million	-0.616x	-180.00%
2009-12-31	CN¥-178.12 Million ≈ $-26.06 Million	CN¥39.16 Million ≈ $5.73 Million	-0.220x	-143.65%
2008-12-31	CN¥-230.81 Million ≈ $-33.78 Million	CN¥20.83 Million ≈ $3.05 Million	-0.090x	-367.44%
2007-12-31	CN¥-362.40 Million ≈ $-53.03 Million	CN¥7.00 Million ≈ $1.02 Million	-0.019x	+61.55%
2006-12-31	CN¥-429.60 Million ≈ $-62.86 Million	CN¥21.57 Million ≈ $3.16 Million	-0.050x	-110.15%
2005-12-31	CN¥327.77 Million ≈ $47.96 Million	CN¥162.12 Million ≈ $23.72 Million	0.495x	+616.00%
2004-12-31	CN¥489.71 Million ≈ $71.66 Million	CN¥33.83 Million ≈ $4.95 Million	0.069x	+1796.70%
2003-12-31	CN¥391.64 Million ≈ $57.31 Million	CN¥1.43 Million ≈ $208.72K	0.004x	-91.75%
2002-12-31	CN¥351.79 Million ≈ $51.48 Million	CN¥15.54 Million ≈ $2.27 Million	0.044x	+238.60%
2001-12-31	CN¥333.98 Million ≈ $48.87 Million	CN¥-10.64 Million ≈ $-1.56 Million	-0.032x	-183.07%
2000-12-31	CN¥117.80 Million ≈ $17.24 Million	CN¥4.52 Million ≈ $661.33K	0.038x	-93.81%
1999-12-31	CN¥113.38 Million ≈ $16.59 Million	CN¥70.28 Million ≈ $10.28 Million	0.620x	--

About Qinghai Spring Medicinal Resources Technology Co Ltd

SHG:600381 China Drug Manufacturers - Specialty & Generic

Market Cap

$444.13 Million

CN¥3.04 Billion CNY

Market Cap Rank

#13198 Global

#4050 in China

Share Price

CN¥5.17

Change (1 day)

+5.08%

52-Week Range

CN¥2.61 - CN¥5.58

All Time High

CN¥24.91